Biogen (BIIB) Deferred Taxes (2009 - 2026)

Biogen has reported Deferred Taxes for 18 years, with the latest figure at -$27.6 million in Q2 2026.

• On a quarterly basis, Deferred Taxes rose 11.82% year-over-year to -$27.6 million in Q2 2026; TTM through Jun 2026 was $416.7 million, a 344.97% increase from a year earlier, with the FY2025 full-year figure at $361.6 million, up 328.72% from the prior year.
• Deferred Taxes was -$27.6 million for Q2 2026 at Biogen, down from $23.6 million in the prior quarter.
• The five-year high for Deferred Taxes was $253.8 million in Q3 2025, with the low at -$206.8 million in Q3 2023.
• Average Deferred Taxes over 5 years is -$15.3 million, with a median of -$30.0 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Deferred Taxes sank 6550.0% in 2023, then surged 582.51% in 2025.
• Over 5 years, Deferred Taxes stood at -$28.8 million in 2022, then soared by 349.65% to $71.9 million in 2023, then sank by 181.22% to -$58.4 million in 2024, then surged by 385.79% to $166.9 million in 2025, then slumped by 116.54% to -$27.6 million in 2026.
• The last three Deferred Taxes figures came in at -$27.6 million (Q2 2026), $23.6 million (Q1 2026), and $166.9 million (Q4 2025), per Business Quant data.